• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, November 17, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Review Evaluates Mesenchymal Stem Cell Immune Modulation to Slow ALS Progression

by
November 9, 2026
in Health
Reading Time: 2 mins read
0
Review Evaluates Mesenchymal Stem Cell Immune Modulation to Slow ALS Progression

Review Evaluates Mesenchymal Stem Cell Immune Modulation to Slow ALS Progression

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Mesenchymal stem cells may slow the progression of amyotrophic lateral sclerosis by suppressing neuroinflammation through the induction of regulatory T cells, according to a peer-reviewed review published in the Journal of Translational Medicine. Authors Thomas E. Ichim and Neil H. Riordan evaluate the therapeutic potential of cellular immunomodulation against amyotrophic lateral sclerosis, which remains a uniformly fatal motor neuron disease. While neuroinflammation is recognized as a key contributor to disease progression, clinically effective immune-modulating therapies for the condition have remained limited.

The review notes that widespread clinical enthusiasm for stem cell therapy has historically centered on tissue regeneration and rejuvenation. However, the authors point out that the initial Food and Drug Administration approval granted for mesenchymal stem cells was established for immune modulation in graft-versus-host disease, rather than for structural tissue repair. Drawing on this immunomodulatory foundation, the analysis focuses on the biological mechanisms through which mesenchymal stem cells influence immune pathways, emphasizing how the generation and expansion of regulatory T cells could counteract neuroinflammatory activity in motor neuron disorders.

Despite the biological rationale for cell-based immunotherapy, clinical results observed to date in amyotrophic lateral sclerosis trials have been mixed.

To overcome these mixed clinical outcomes, the authors argue for the integration of prospective biomarker monitoring within future therapeutic strategies. Implementing systematic tracking of immune and blood-based biomarkers could sharpen clinical protocols by refining patient selection criteria, directing the selection of optimal cell types and adjuvants, and properly calibrating treatment intensity.

Ultimately, the review concludes that regulatory T cells induced by mesenchymal stem cells represent a promising immunomodulatory mechanism to mitigate neuroinflammation and slow disease progression in amyotrophic lateral sclerosis.

Subject of Research: Mesenchymal stem cell therapy and regulatory T cell modulation in amyotrophic lateral sclerosis

Article Title: Immunological aspects of mesenchymal stem cell therapy for ALS

Article References: Ichim, T. E., & Riordan, N. H. (2026). Immunological aspects of mesenchymal stem cell therapy for ALS. Journal of Translational Medicine. https://doi.org/10.1186/s12967-026-09086-x

Image Credits: AI Generated

DOI: 10.1186/s12967-026-09086-x

Keywords: Amyotrophic lateral sclerosis, Mesenchymal stem cells, Regulatory T cells, Neuroinflammation, Immunomodulation, Biomarkers, Translational medicine, Clinical trials, Immunological, aspects, mesenchymal, stem

News Source: Drew Townsend. (November 9, 2026). Review Evaluates Mesenchymal Stem Cell Immune Modulation to Slow ALS Progression. Scienmag.

Tags: amyotrophic lateral sclerosisaspectsbiomarkersClinical Trialsimmunologicalimmunomodulationmesenchymalmesenchymal stem cellsNeuroinflammationregulatory T cellsstemtranslational medicine
Share12Tweet7Share2ShareShareShare1

Related Posts

Ketogenic Diet Improves Renal Fanconi Syndrome in Single Pediatric Cystinosis Case

Ketogenic Diet Improves Renal Fanconi Syndrome in Single Pediatric Cystinosis Case

November 17, 2026
Most Patients Achieve Pouch Preservation Using Endoscopic or Revisional Approaches, Narrative Review Finds

Most Patients Achieve Pouch Preservation Using Endoscopic or Revisional Approaches, Narrative Review Finds

November 17, 2026

Muscle Oxidative Capacity Drops by Half in Children with Cerebral Palsy

November 17, 2026

Global Health Worker Migration Requires Competency Benchmarking Beyond Qualification Recognition

November 17, 2026

POPULAR NEWS

  • Vitamin A Deficiency Persists in Congolese Children Despite Long-Term Supplementation Efforts

    Vitamin A Deficiency Persists in Congolese Children Despite Long-Term Supplementation Efforts

    29 shares
    Share 12 Tweet 7
  • Veterinarians Identify Twelve Defences to Improve Medication Safety in Sows

    29 shares
    Share 12 Tweet 7
  • Ascending Aorta Shows Marked Elongation Before Dissection Despite Only Moderate Dilatation

    29 shares
    Share 12 Tweet 7
  • Rural Australian Hospital Study Links Insulin and Polypharmacy to Medication Readmissions

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Physicians Prioritize Survival Benefits in Treating Advanced Non–Small Cell Lung Cancer

Ketogenic Diet Improves Renal Fanconi Syndrome in Single Pediatric Cystinosis Case

Self-Supervised Framework Enhances Anomaly Detection Accuracy Across Dynamic Internet of Things Networks

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.